CLINICAL_TRIALS
trial_result
· 2017-02-24
Clinical Trial Update: A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes [Phase 1]
Summary
A Phase 1 study evaluating the diabetes drug candidate NNC 55-0414 in adults with Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED